01:24 AM EDT, 08/25/2026 (MT Newswires) -- Molecular Partners (MOLN.SW) said Tuesday its net loss narrowed in the first half. Net loss attributable to shareholders for the six months ended June 30 was 26.7 million francs, compared with 37.2 million francs earlier. Loss per share moved to 0.70 franc from 1 franc. The clinical-stage biotech company did not report revenue for the six-month period.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.